These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31982258)

  • 21. 5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial.
    Bhattacharya SK; Sur D; Ali M; Kanungo S; You YA; Manna B; Sah B; Niyogi SK; Park JK; Sarkar B; Puri MK; Kim DR; Deen JL; Holmgren J; Carbis R; Dhingra MS; Donner A; Nair GB; Lopez AL; Wierzba TF; Clemens JD
    Lancet Infect Dis; 2013 Dec; 13(12):1050-6. PubMed ID: 24140390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Achievements and challenges for the use of killed oral cholera vaccines in the global stockpile era.
    Desai SN; Pezzoli L; Alberti KP; Martin S; Costa A; Perea W; Legros D
    Hum Vaccin Immunother; 2017 Mar; 13(3):579-587. PubMed ID: 27813703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholera vaccine: new preventive tool for endemic countries.
    Verma R; Khanna P; Chawla S
    Hum Vaccin Immunother; 2012 May; 8(5):682-4. PubMed ID: 22634452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of oral cholera vaccine as a vaccine probe to determine the burden of culture-negative cholera.
    Im J; Islam MT; Ahmmed F; Kim DR; Chon Y; Zaman K; Khan AI; Ali M; Marks F; Qadri F; Clemens JD
    PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007179. PubMed ID: 30870416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lessons learnt from 12 oral cholera vaccine campaigns in resource-poor settings.
    Hsiao A; Desai SN; Mogasale V; Excler JL; Digilio L
    Bull World Health Organ; 2017 Apr; 95(4):303-312. PubMed ID: 28479625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive Review on the Use of Oral Cholera Vaccine (OCV) in Ethiopia: 2019 to 2023.
    Edosa M; Jeon Y; Gedefaw A; Hailu D; Mesfin Getachew E; Mogeni OD; Jang GH; Mukasa D; Yeshitela B; Getahun T; Lynch J; Bouhenia M; Worku Demlie Y; Hussen M; Wossen M; Teferi M; Park SE
    Clin Infect Dis; 2024 Jul; 79(Supplement_1):S20-S32. PubMed ID: 38996040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Euvichol story - Development and licensure of a safe, effective and affordable oral cholera vaccine through global public private partnerships.
    Odevall L; Hong D; Digilio L; Sahastrabuddhe S; Mogasale V; Baik Y; Choi S; Kim JH; Lynch J
    Vaccine; 2018 Oct; 36(45):6606-6614. PubMed ID: 30314912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of Oral Cholera Vaccine in Haiti: 37-Month Follow-Up.
    Sévère K; Rouzier V; Anglade SB; Bertil C; Joseph P; Deroncelay A; Mabou MM; Wright PF; Guillaume FD; Pape JW
    Am J Trop Med Hyg; 2016 May; 94(5):1136-42. PubMed ID: 26928838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feasibility, coverage and cost of oral cholera vaccination conducted by icddr,b using the existing national immunization service delivery mechanism in rural setting Keraniganj, Bangladesh.
    Khan AI; Khan IA; Siddique SA; Rahman A; Islam MT; Bhuiya MAI; Saha NC; Biswas PK; Saha A; Chowdhury F; Qadri F
    Hum Vaccin Immunother; 2019; 15(6):1302-1309. PubMed ID: 30261152
    [No Abstract]   [Full Text] [Related]  

  • 30. Considerations for oral cholera vaccine use during outbreak after earthquake in Haiti, 2010-2011.
    Date KA; Vicari A; Hyde TB; Mintz E; Danovaro-Holliday MC; Henry A; Tappero JW; Roels TH; Abrams J; Burkholder BT; Ruiz-Matus C; Andrus J; Dietz V
    Emerg Infect Dis; 2011 Nov; 17(11):2105-12. PubMed ID: 22099114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of oral cholera vaccine in Haiti: a rural demonstration project.
    Ivers LC; Teng JE; Lascher J; Raymond M; Weigel J; Victor N; Jerome JG; Hilaire IJ; Almazor CP; Ternier R; Cadet J; Francois J; Guillaume FD; Farmer PE
    Am J Trop Med Hyg; 2013 Oct; 89(4):617-624. PubMed ID: 24106187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral Cholera Vaccination Delivery Cost in Low- and Middle-Income Countries: An Analysis Based on Systematic Review.
    Mogasale V; Ramani E; Wee H; Kim JH
    PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005124. PubMed ID: 27930668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Challenges for programmatic implementation of killed whole cell oral cholera vaccines for prevention and control of cholera: a meta-opinion.
    Chatterjee P; Kanungo S; Dutta S
    Expert Opin Biol Ther; 2018 Sep; 18(9):983-988. PubMed ID: 30107757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Global economic evaluation of oral cholera vaccine: A systematic review.
    Teoh SL; Kotirum S; Hutubessy RCW; Chaiyakunapruk N
    Hum Vaccin Immunother; 2018 Feb; 14(2):420-429. PubMed ID: 29099647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A rapid qualitative assessment of oral cholera vaccine anticipated acceptability in a context of resistance towards cholera intervention in Nampula, Mozambique.
    Démolis R; Botão C; Heyerdahl LW; Gessner BD; Cavailler P; Sinai C; Magaço A; Le Gargasson JB; Mengel M; Guillermet E
    Vaccine; 2018 Oct; 36(44):6497-6505. PubMed ID: 29174106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral cholera vaccination strategy: Self-administration of the second dose in urban Dhaka, Bangladesh.
    Khan AI; Islam MS; Islam MT; Ahmed A; Chowdhury MI; Chowdhury F; Siddik MAU; Clemens JD; Qadri F
    Vaccine; 2019 Feb; 37(6):827-832. PubMed ID: 30639459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uptake during an oral cholera vaccine pilot demonstration program, Odisha, India.
    Kar SK; Pach A; Sah B; Kerketta AS; Patnaik B; Mogasale V; Kim YH; Rath SB; Shin S; Khuntia HK; Bhattachan A; Puri MK; Wierzba TF; Kaljee LM
    Hum Vaccin Immunother; 2014; 10(10):2834-42. PubMed ID: 25483631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of an oral cholera vaccine campaign to prevent clinically-significant cholera in Odisha State, India.
    Wierzba TF; Kar SK; Mogasale VV; Kerketta AS; You YA; Baral P; Khuntia HK; Ali M; Kim YH; Rath SB; Bhattachan A; Sah B
    Vaccine; 2015 May; 33(21):2463-9. PubMed ID: 25850019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety of the oral cholera vaccine in pregnancy: Retrospective findings from a subgroup following mass vaccination campaign in Dhaka, Bangladesh.
    Khan AI; Ali M; Chowdhury F; Saha A; Khan IA; Khan A; Akter A; Asaduzzaman M; Islam MT; Kabir A; You YA; Saha NC; Cravioto A; Clemens JD; Qadri F
    Vaccine; 2017 Mar; 35(11):1538-1543. PubMed ID: 28196715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Willingness to pay for oral cholera vaccines in urban Bangladesh.
    Sarker AR; Islam Z; Sultana M; Sheikh N; Mahumud RA; Islam MT; Meer RV; Morton A; Khan AI; Clemens JD; Qadri F; Khan JAM
    PLoS One; 2020; 15(4):e0232600. PubMed ID: 32353086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.